Pharmacie by Medi-Market Group - Gent
0649.618.896 · rovalta.com · 27/09/2026
NORMAL SITUATION
Pharmacie by Medi-Market Group - Gent
Company — Normal situation.
Strike-off: 25 juin 2026
Financial year 2025 · Closed on 31/12/2025
Net result4,9 k €-30,1 %over 1 year
Gross margin48,8 k €-6,1 %over 1 year
Equity118 k €+4,3 %over 1 year
Workforce0,0 ETP
Overview
Identity
Source · BCE/KBOPharmacie by Medi-Market Group - Gent is a Public limited company incorporated in 2016.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0649.618.896
- Incorporation
- 03/03/2016
- Legal form
- Public limited company
- Contributed capital
- 62 000,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 0,0 ETP
Joint committees (1)
- 313
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 9 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 48,8 k € | -6.1% | 52 k € | -7.5% | 56,2 k € | -22.6% | 72,6 k € | -5.5% | 76,8 k € |
| EBITDA | 44,8 k € | -12.9% | 51,4 k € | -7.8% | 55,8 k € | -22.3% | 71,8 k € | -2.7% | 73,8 k € |
| Operating result | 11,9 k € | -34.6% | 18,2 k € | -17.7% | 22,1 k € | -41.8% | 38,1 k € | +8.2% | 35,2 k € |
| Net result | 4,9 k € | -30.1% | 7 k € | +6.5% | 6,6 k € | -75.7% | 27 k € | +24.2% | 21,8 k € |
| Balance sheet | |||||||||
| Equity | 118 k € | +4.3% | 113,1 k € | +6.6% | 106,1 k € | +6.6% | 99,5 k € | +37.3% | 72,5 k € |
| Total assets | 384,1 k € | -4.8% | 403,4 k € | -12.2% | 459,6 k € | -3.5% | 476,2 k € | -18.3% | 582,9 k € |
| Cash | – | – | – | – | 0 € | ||||
| Debts | 266,1 k € | -8.3% | 290,3 k € | -17.9% | 353,4 k € | -6.2% | 376,7 k € | -26.2% | 510,4 k € |
| Other | |||||||||
| Workforce | 0,0 ETP | – | – | 0,0 ETP | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20251 active · 7 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director | since 01/06/2021 | 00 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director | since 30/12/2020 | 00 | |
| Director | 03/03/2016 → 09/06/2022 | ||
Verougstraete Yvan | Director | 03/03/2016 → 09/06/2022 | 0 |
| Director | 02/03/2016 → 09/06/2022 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 01/07/2026 | 02/07/2025 | 23/07/2024 | 29/08/2023 | 30/03/2023 | 28/03/2022 |
| General meeting | 29/06/2026 | 27/06/2025 | 01/07/2024 | 25/08/2023 | 30/03/2023 | 28/03/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 29/06/2026 | 01/07/2026 | French | |
| Abridged model | 31/12/2024 | 27/06/2025 | 02/07/2025 | French | |
| Abridged model | 31/12/2023 | 01/07/2024 | 23/07/2024 | French | |
| Abridged model | 31/12/2022 | 25/08/2023 | 29/08/2023 | French | |
| Abridged model | 31/12/2021 | 30/03/2023 | 30/03/2023 | French | |
| Abridged model | 31/12/2020 | 28/03/2022 | 28/03/2022 | French | |
| Abridged model | 31/12/2019 | 18/12/2020 | 18/12/2020 | French | |
| Abridged model | 31/12/2018 | 17/07/2019 | 23/07/2019 | French | |
| Abridged model | 31/12/2017 | 29/06/2018 | 03/07/2018 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 7 ended
Active mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director | since 01/06/2021 | 00 |
Ended mandates
| Director | Function | Mandate | Other mandatescurrentendedstruck offbankruptcies |
|---|---|---|---|
| Director | since 30/12/2020 | 00 | |
| Director | 03/03/2016 → 09/06/2022 | ||
Verougstraete Yvan | Director | 03/03/2016 → 09/06/2022 | 0 |
| Director | 02/03/2016 → 09/06/2022 |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Restructuring02/07/2026ASSEMBLEE GENERALE EXTRAORDINAIRE - Fusion par absorption
- Restructuring07/05/2026Projet de fusion - Pouvoirs
- Other09/09/2025Renouvellement du mandat du commisaire - Pouvoirs ;
- Mandates06/02/2023DEMISSIONS, NOMINATIONS
- Mandates05/08/2021DEMISSIONS, NOMINATIONS
- Mandates20/01/2021ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Mandates07/02/2020DEMISSIONS, NOMINATIONS
- Other28/11/2018STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20254,9 k €↓
- 2024Annual accounts 20247 k €↑
- 2023Annual accounts 20236,6 k €↓
- 2022Annual accounts 202227 k €↑
- 2021Annual accounts 202121,8 k €↑
- 2018Annual accounts 201811,9 k €↑
- 2018Name changePharmacie by Medi-Market Group - Gent
- 2017Annual accounts 2017-80,3 k €
- 03/03/2016IncorporationPublic limited company
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Avenue Cicéron 7, 1140 Evere | CBE until 25/06/2026 | CBE |
| Avenue Cicéron 7, 1140 Evere | accounts 2021 → 2025 | Accounts 2025 · 2026-00269839 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Pharmacie by Medi-Market Group - Gent | CBE until 25/06/2026 | CBE |
| Pharmacie by Medi-Market Group - Gent | accounts 2018 → 2025 | Accounts 2025 · 2026-00269839 |
| PharmaClic Gent | accounts 2017 | Accounts 2017 · 2018-29900415 |
Annual accounts date a value by the financial year it appears in. The CBE dates a change to the day, but its history has only been kept since 27/09/2026.